CrushSCI.com
Journal Selection & Manuscript Polishing Services
NATURE GENETICS journal cover Management
Back to journal directory

Review Cycle Records

NATURE GENETICS

Springer SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 1 TOP2025 JCR Q1
743.6Average days
578Median days
494Fastest days
1,328Longest days
4362025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

1,328 days

High-resolution promoter interaction analysis implicates genes involved in activation of type 3 innate lymphoid cells in immune disease risk

AuthorsValeriya Malysheva; Helen Ray-Jones; Nora Lakes; Rachel A. Brown; Tareian A. Cazares; Owen Clay; David E. Ohayon; Pavel Artemov; Joseph A. Wayman; Zi F. Yang; Monica Della Rosa; Carmen Petitjean; Clarissa Booth; Joseph I. J. Ellaway; Jenna R. Barnes; Andrew W. Dangel; Ankita Saini; William R. Orchard; Xiaoting Chen; Sreeja Parameswaran; Frances Burden; Mattia Frontini; Takashi Nagano; Peter Fraser; Stefan Schoenfelder; Matthew T. Weirauch; Leah C. Kottyan; David F. Smith; Nick Powell; Jill M. Weimer; Eugene M. Oltz; Chris Wallace; Emily R. Miraldi; Stephen N. Waggoner; Mikhail Spivakov

Affiliations1. MRC Laboratory of Medical Sciences, London, UK; 2. Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK; 3. VIB, Center for Molecular Neurology, Antwerp, Belgium; 4. Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium; 5. VIB, Center for AI and Computational Biology, Leuven, Belgium; 6. Trinity Hall, University of Cambridge, Cambridge, UK; 7. Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands; 8. Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, USA; 9. Medical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, USA; 10. Division of Human Genetics and Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 11. Department of Microbial Infection and Immunity, The Ohio State University, Columbus, USA; 12. Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA; 13. Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 14. Eli Lilly and Company, Indianapolis, USA; 15. Division of Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 16. Section of Pediatric Rheumatology, Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, USA; 17. Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK; 18. NeoGenomics, Cambridge, UK; 19. British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; 20. Heart and Lung Research Institute, University of Cambridge, Cambridge, UK; 21. Center for Genetics and Rare Diseases, Sanford Research, Sioux Falls, USA; 22. European Bioinformatics Institute, Hinxton, UK; 23. University of Cambridge, Cambridge, UK; 24. Cancer Research UK Cambridge Research Institute, Cambridge, UK; 25. Department of Haematology, University of Cambridge, Cambridge, UK; 26. National Health Service (NHS) Blood and Transplant, Cambridge, UK; 27. University of Kent, Canterbury, UK; 28. Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter Medical School, Exeter, UK; 29. The Babraham Institute, Cambridge, UK; 30. Laboratory for Nuclear Dynamics, Institute for Protein Research, Osaka University, Osaka, Japan; 31. Institute of Medical Science, University of Tokyo, Tokyo, Japan; 32. Department of Biological Sciences, Florida State University, Tallahassee, USA; 33. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, USA; 34. Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 35. Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 36. Division of Allergy and Immunology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 37. Department of Otolaryngology, Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, USA; 38. Divisions of Pediatric Otolaryngology and Pulmonary & Sleep Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 39. Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; 40. MRC Biostatistics Unit, Cambridge Biomedical Campus, Cambridge Institute of Public Health, Cambridge, UK; 41. Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK

Source PDF DOI Publisher page
578 days

Mapping enhancer–gene regulatory interactions from single-cell data

AuthorsMaya U. Sheth; Wei-Lin Qiu; X. Rosa Ma; Andreas R. Gschwind; Evelyn Jagoda; Anthony S. Tan; James Galante; Judhajeet Ray; Dulguun Amgalan; Hjörleifur Einarsson; Bram L. Gorissen; Danilo Dubocanin; Christopher S. McGinnis; Jacob Huang; Glen Munson; Kayla Brand; Ansuman T. Satpathy; Thouis R. Jones; Lars M. Steinmetz; Anshul Kundaje; Berk Ustun; Jesse M. Engreitz; Robin Andersson

Affiliations1. The Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, USA; 2. Department of Genetics, Stanford University School of Medicine, Stanford, USA; 3. Basic Sciences and Engineering Initiative, Betty Irene Moore Children’s Heart Center, Lucile Packard Children’s Hospital, Stanford, USA; 4. Department of Bioengineering, Stanford University, Stanford, USA; 5. Department of Biology, Section for Computational and RNA Biology, University of Copenhagen, Copenhagen, Denmark; 6. Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, USA; 7. Department of Pathology, Stanford University, Stanford, USA; 8. Parker Institute for Cancer Immunotherapy, San Francisco, USA; 9. Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany; 10. Stanford Genome Technology Center, Stanford University School of Medicine, Palo Alto, USA; 11. Department of Computer Science, Stanford University, Stanford, USA; 12. Halıcıoğlu Data Science Institute and Department of Computer Science and Engineering, University of California San Diego, San Diego, USA; 13. Gene Regulation Observatory, Broad Institute of MIT and Harvard, Cambridge, USA; 14. Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, USA

Source PDF DOI Publisher page
494 days

Cumulative transcription factor binding and p300-mediated histone acetylation drive enhancer activation frequency

AuthorsValentina Baderna; Guido Barzaghi; Rozemarijn Kleinendorst; Kasit Chatsirisupachai; Laura Moniot-Perron; Colm Doyle; Meike Schopp; Tino Hochepied; Claude Libert; Duncan T. Odom; Judith B. Zaugg; Arnaud R. Krebs

Affiliations1. Genome Biology Unit, EMBL Heidelberg, Heidelberg, Germany; 2. Faculty of Biosciences, Collaboration for Joint PhD Degree between EMBL and Heidelberg University, Heidelberg, Germany; 3. Institut Imagine, Paris, France; 4. Division of Precision Medicine, NYU Grossman School of Medicine, New York City, USA; 5. Division of Medical Bioinformatics, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; 6. German Cancer Research Center (DKFZ), Division of Regulatory Genomics and Cancer Evolution, Heidelberg, Germany; 7. VIB Center for Inflammation Research, Ghent, Belgium; 8. Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium; 9. Structural and Computational Biology Unit, EMBL Heidelberg, Heidelberg, Germany; 10. Department of Biomedicine, University of Basel, Basel, Switzerland

Source PDF DOI Publisher page
750 days

Gene mutant dosage is associated with prognosis and metastatic tropism in 60,000 clinical cancer samples

AuthorsNicola Calonaci; Eriseld Krasniqi; Daniel Colic; Stefano Scalera; Giorgia Gandolfi; Salvatore Milite; Konstantin Bräutigam; Andrea Sottoriva; Trevor A. Graham; Leonardo Egidi; Biagio Ricciuti; Marcello Maugeri-Saccà; Giulio Caravagna

Affiliations1. Department of Mathematics, Informatics and Geosciences, University of Trieste, Trieste, Italy; 2. Phase IV Clinical Studies Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy; 3. Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute for Science and Technology (BIST), Barcelona, Spain; 4. Clinical Trial Center, Biostatistics and Bioinformatics Division, IRCCS Regina Elena National Cancer Institute, Rome, Italy; 5. Computational Biology Research Centre, Human Technopole, Milan, Italy; 6. Centre for Evolution and Cancer, Institute of Cancer Research, London, UK; 7. Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland; 8. Department of Economics, Business, Mathematics, and Statistics ‘Bruno de Finetti’, University of Trieste, Trieste, Italy; 9. Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, USA; 10. Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy; 11. Area Science Park, Trieste, Italy

Source PDF DOI Publisher page
568 days

Single-cell spatial mapping of human kidney development implicates the microenvironment in guiding cell fate decisions

AuthorsJonathan Levinsohn; Samuel Grindel; Bernhard Dumoulin; Amin Abedini; Carolina Conte; Aria Zheyuan Huang; Rena Levin-Klein; Boaz Weisz; Grace Rabinowitz; Andi M. Bergeson; Eunji Ha; Konstantin A. Klötzer; Nancy Zhang; Paul Titchenell; Mingyao Li; Joo-Seop Park; Juan Pablo Arroyo; Laura S. Finn; Kotaro Sasaki; Pazit Beckerman; Oren Pleniceanu; Paola Romagnani; Alex J. Hughes; Katalin Susztak

Affiliations1. Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA; 2. Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA; 3. Penn/CHOP Kidney Innovation Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA; 4. Department of Genetics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA; 5. Department of Pediatrics, Division of Nephrology, Children’s Hospital of Philadelphia, Philadelphia, USA; 6. Department of Bioengineering, University of Pennsylvania, Philadelphia, USA; 7. Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, USA; 8. Nephrology and Dialysis Unit, Meyer Children’s Hospital IRCCS, Florence, Italy; 9. Department of Biomedical, Experimental and Clinical Sciences ‘Mario Serio’, University of Florence, Florence, Italy; 10. Kidney Research Lab, Institute of Nephrology and Hypertension, Sheba Medical Center, Tel Aviv, Israel; 11. Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel; 12. Department of Obstetrics and Gynecology, Fetal Medicine Unit, Sheba Medical Center, Ramat Gan, Israel; 13. Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, USA; 14. Department of Physiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA; 15. Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA; 16. Division of Nephrology and Hypertension, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA; 17. Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, USA; 18. Vanderbilt Center for Kidney Disease, Vanderbilt University Medical Center, Nashville, USA; 19. Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, USA; 20. Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.